Torrent Pharma Peer Comparison

NSE: TORNTPHARM | BSE: 500420

₹4,613.40

₹33.40 (0.73%)

As on 30-Oct-2026IST

Market cap

₹1,76,306 Cr

Revenue (TTM)

₹17,400 Cr

P/E Ratio

P/B Ratio

9.6

Div. Yield

0.8 %

Edit

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Market cap (₹ Cr)	1,76,306	4,26,662	1,11,489	1,12,699	1,02,797
Revenue (₹ Cr)	17,400	61,631	28,139	33,097	15,379
Net Profit (₹ Cr)	2,099.00	11,037.19	2,868.29	2,759.70	2,249.69
Net Margin (%)	12.10	17.23	9.94	8.03	14.32
RoE (%)	16.47	14.23	8.90	7.30	13.86
Price to Earnings	83.01	38.91	38.48	40.25	45.84
Price-To-Book	9.60	4.93	3.15	2.90	5.85

Income Statement (₹ Cr)

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Operating Revenue	17,400.00	61,630.92	28,138.89	33,097.40	15,378.58
Total Income	17,348.00	64,063.12	28,855.45	34,352.50	15,705.47
Total Expenditure	11,626.00	43,720.59	23,306.78	28,236.90	11,301.83
EBITDA	5,774.00	17,910.33	4,832.11	4,860.50	4,076.75
Depreciation	1,916.00	3,004.86	1,352.39	2,141.40	907.11
EBIT	3,858.00	14,905.47	3,479.72	2,719.10	3,169.64
Interest	886.00	338.59	60.93	450.40	513.87
Other Income	-52.00	2,432.20	716.56	1,255.10	326.89
Exceptional Items	-107.00	-1,962.40	-275.91	0.00	-129.75
Profit before Tax	2,813.00	15,036.68	3,859.44	3,523.80	2,852.91
Provision for Tax	714.00	3,999.49	991.15	764.10	603.22
Profit after Tax	2,099.00	11,037.19	2,868.29	2,759.70	2,249.69

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Shareholder's Funds	18,373.00	89,279.88	35,395.50	38,807.00	17,582.22
Minority Interest	25.00	-20.97	43.21	40.20	-20.87
Non-Current Liabilities	18,258.00	1,683.12	935.18	3,074.90	5,214.33
Current Liabilities	7,984.00	23,591.58	6,976.93	15,430.30	5,884.79
Total Liabilities	43,613.69	1,08,407.20	42,342.71	56,576.70	27,754.83

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Non-Current Assets	33,165.00	44,135.45	16,372.16	26,891.10	20,096.89
Current Assets	10,517.00	69,266.58	25,060.80	29,732.20	7,956.27
Total Assets	43,613.69	1,08,407.20	42,342.71	56,576.70	27,754.83
Total Debt*	14,798.24	4,081.61	257.97	7,734.10	6,021.78
Net Current Assets	2,533.00	45,675.00	18,083.87	14,301.90	2,071.48
Contingent Liabilities	379.25	1,587.05	987.37	336.14	924.77

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Cash From Operating Activities	3,022.71	12,419.18	3,940.02	5,673.70	3,121.29
Cash Flow from Investing Activities	-12,712.41	-11,344.05	-2,326.13	-6,549.30	-196.42
Cash from Financing Activities	10,150.60	-2,512.55	-1,233.65	829.00	-2,952.69
Net Cash Inflow / Outflow	460.90	-1,437.42	380.24	-46.60	-27.82

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
ROCE (%)	19.27	19.11	16.00	13.75	13.24
ROE (%)	16.47	14.23	8.90	7.30	13.86
ROA (%)	6.98	10.10	6.86	4.93	7.79
EBIT Margin (%)	22.17	24.19	12.37	8.22	20.61
Net Margin (%)	12.10	17.23	9.94	8.03	14.32
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Revenue Growth (%)	42.06	12.13	-0.74	-3.53	13.53
EBIT Growth (%)	21.02	7.78	-42.59	-58.47	31.59
Net Profit Growth (%)	-1.92	4.94	-47.41	-51.77	27.79
EPS Growth (%)	-1.09	6.57	-42.93	-51.50	34.22
Book Value Growth (%)	10.51	15.72	10.59	12.99	13.74

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Price / Earnings	73.16	34.69	35.89	40.25	43.76
Price / Book Value	9.60	4.93	3.15	2.90	5.85
Dividend Yield (%)	0.82	0.90	0.94	0.59	0.04
EV/EBITDA	32.75	22.23	21.27	23.33	26.20
Market Cap (₹ Cr)	1,42,851.87	4,21,639.92	98,797.18	1,04,763.81	82,801.75

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Debt to Equity	0.63	0.00	0.00	0.00	0.17
Short term debt to equity ratio	0.35	0.05	0.00	0.16	0.04
Current Ratio	1.32	2.94	3.59	1.93	1.35
Quick Ratio	0.92	2.40	2.62	1.40	0.95
Interest Coverage	4.17	45.41	64.34	8.82	6.55

	Torrent Pharma	Sun Pharmaceutical	Cipla	Dr. Reddy'S Labs	Mankind Pharma
Debtors to sales (%)	19.53	28.89	21.32	30.64	14.17
Asset Turnover	0.58	0.56	0.67	0.59	0.53
Receivable days	45.41	89.14	52.05	103.79	39.93
Inventory Days	52.67	67.85	57.25	79.94	51.78
Payable days	244.06	213.72	115.96	84.78	111.46
Cash Conversion Cycle	-145.98	-56.72	-6.65	98.95	-19.75

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.